dysentery: Acute inflammation of the intestine associated with infectious diarrhea of various etiologies, generally acquired by eating contaminated food containing toxins, biological derived from bacteria or other microorganisms. Dysentery is characterized initially by watery feces then by bloody mucoid stools. It is often associated with abdominal pain; fever; and dehydration.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
61 |
4. Check minimum number of eventsNone |
61 |
5. Include endpointsNone |
61 |
6. Filter based on genotype QC (FinnGen only) |
61 |
Control definitions (FinnGen only)
- Control exclude
- IBD_BACT_INTEST_INFECTIONS
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- A04
- Name in latin
- Infectio ab Escherichia coli enterohaemorrhagica
Similar endpoints
↥List of similar endpoints to
Enterohaemorrhagic Escherichia coli infection
based on the number of shared cases.
Similar with more cases:
- Bacterial intestinal infections, IBD co-morbidities
- Other bacterial intestinal infections
- Infections, IBD-co-morbidities
- Intestinal infectious diseases
- Certain infectious and parasitic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 663 | 320 | 339 |
| Only index persons | 530 | 259 | 271 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 18.74 | 22.76 | 14.55 |
| Only index persons | 26.35 | 31.04 | 21.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 61 | 38 | 23 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 54.07 | 54.06 | 54.07 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 54
- Matched controls
- 541
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A04.3
ICD-10 Finland
Enterohaemorrhagic Escherichia coli infection
+∞
72.1
52
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
10.9
13.9
32
63
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
10
19.57
17.36
3.3
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
26
11.79
16.86
3.6
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
31
97
5.46
9.94
8.0
5.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
6
26.92
9.83
2.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
19
8.42
8.82
2.6
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
14
8.35
6.92
3.3
2.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
13
28
5.63
6.06
10.2
9.5
mmol/l
9.0
7.4
0.34
13
28
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
22
5.88
5.49
2.7
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
31
5.06
5.40
2.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
21
74
3.80
5.31
3.5
1.7
ug/g
379.6
121.2
0.93
16
60
(42870588) Differential panel, method unspecified - Blood
32
149
3.41
5.28
12.6
5.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
6
15.05
5.24
3.6
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
6
15.05
5.24
3.6
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
8
11.27
4.67
2.1
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
31
4.57
4.50
13.4
19.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
40
229
3.17
4.43
12.7
6.1
%
61.2
57.4
1.05
40
221
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
6
12.94
4.39
4.0
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
6
12.94
4.39
4.0
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
6
12.94
4.39
4.0
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
6
12.94
4.39
4.0
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
40
232
3.10
4.27
13.1
6.1
%
23.9
28.1
1.59
40
222
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
10
8.99
4.20
2.4
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
10
8.99
4.20
2.5
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
34
4.15
4.00
1.9
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
11
8.17
4.00
3.6
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
14
45
3.74
3.94
1.9
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
29
150
2.78
3.69
5.7
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
17
69
3.03
3.31
2.6
1.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
7
11
7.02
3.28
2.9
2.7
g/l
3.5
3.8
—
7
11
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
16
5.58
3.17
2.1
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
39
247
2.61
3.16
12.1
6.3
umol/l
11.1
10.3
0.21
39
234
(36660697) Celiac disease serology panel - Serum
13
46
3.32
3.15
1.5
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
17
5.24
3.03
2.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
17
5.24
3.03
2.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
5
10.72
3.03
1.6
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
23
115
2.61
3.03
16.0
6.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
13
5.92
2.96
1.6
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
13
5.92
2.96
1.6
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
26
141
2.47
2.87
3.9
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
55
3.01
2.85
1.6
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
18
82
2.70
2.82
3.5
2.3
mosm/kgh2o
563.7
567.1
0.02
18
74
(3042936) Bacteria identified in Isolate by Culture
15
62
2.88
2.80
2.7
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
6
8.93
2.80
1.4
3.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
6
8.93
2.80
2.2
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
6
8.93
2.80
1.4
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
28
161
2.37
2.68
5.3
3.4
u/l
29.5
27.4
0.24
28
154
(36304419) Bacteria [Presence] in Urine
23
121
2.45
2.68
5.6
2.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
7
7.64
2.59
5.2
2.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
7
7.64
2.59
3.0
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
7
7.64
2.59
2.8
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
11
40
3.13
2.53
3.0
1.8
nmol/l
353.1
426.5
0.50
11
35
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
12
5.41
2.46
1.7
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
17
4.50
2.44
1.9
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
23
127
2.30
2.37
2.2
2.2
u/l
109.2
139.7
0.66
23
122
(3024561) Albumin [Mass/volume] in Serum or Plasma
28
169
2.21
2.33
11.4
5.1
g/l
32.6
35.9
1.69
28
164
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
19
98
2.36
2.27
4.6
2.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
9
5.93
2.25
3.2
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
46
344
2.37
2.20
5.8
4.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
25
149
2.15
2.11
5.8
2.5
u/l
48.0
59.5
1.15
25
142
(3000494) Fungus identified in Specimen by Culture
13
58
2.58
2.08
1.8
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
45
2.76
2.06
2.4
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
21
3.62
2.03
1.6
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
18
95
2.27
2.02
5.3
2.2
e6/l
6.1
4.4
0.36
18
89
(3001019) Free T4 and TSH panel - Serum or Plasma
8
27
3.25
2.02
1.8
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
10
40
2.79
1.95
6.7
2.1
kpa
5.6
5.6
—
10
40
(3000991) Gas panel - Venous blood
8
28
3.13
1.94
7.9
9.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
17
3.79
1.89
1.0
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
26
163
2.04
1.89
8.3
7.4
inr
1.2
1.2
—
8
49
(3002032) Base excess in Venous blood by calculation
10
41
2.72
1.86
6.7
2.1
mmol/l
1.7
2.3
—
10
29
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
48
2.58
1.83
2.5
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
21
123
2.08
1.81
13.2
3.1
ph
7.4
7.4
—
5
22
(3014111) Lactate [Moles/volume] in Serum or Plasma
7
25
3.03
1.70
8.0
10.2
mmol/l
1.4
1.3
—
7
25
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
14
3.79
1.65
18.0
7.7
mmol/l
25.4
24.6
—
5
14
(3012516) Albumin [Mass/volume] in Urine
18
103
2.06
1.63
3.3
2.9
mg/l
64.6
83.3
—
10
65
(3012544) pH of Venous blood
10
44
2.52
1.63
6.9
2.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
8
33
2.63
1.60
7.5
2.2
kpa
4.8
5.1
—
8
33
(4035726)
7
27
2.79
1.56
2.6
1.3
—
—
—
0
0
(3015736) pH of Urine
29
199
1.87
1.56
4.7
3.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
12
60
2.24
1.50
3.1
2.0
%
21.1
23.9
0.13
12
49
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
53
2.31
1.49
1.5
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
20
124
1.91
1.44
1.8
1.2
g/l
1.8
2.2
0.72
13
81
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
25
167
1.84
1.44
5.6
4.2
ng/l
21.7
40.5
0.70
17
110
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
25
169
1.81
1.38
2.4
1.9
pmol/l
81.0
95.5
0.85
15
82
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
52
449
2.07
1.34
24.6
10.8
ml/min/173m2
90.1
89.2
0.08
41
353
(3022948) Iron [Moles/volume] in Serum or Plasma
13
71
2.06
1.31
3.2
1.9
umol/l
10.6
14.7
0.77
13
61
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
18
2.93
1.31
1.6
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
18
2.93
1.31
2.2
2.1
—
—
—
0
0
(4010399)
8
36
2.40
1.30
1.1
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
37
2.33
1.27
3.6
3.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
19
2.77
1.24
2.8
2.3
—
—
—
0
0
(3019225) pH of Specimen
8
38
2.27
1.24
4.1
3.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
12
65
2.05
1.24
3.7
1.9
g/l
2.5
2.4
0.02
12
56
(3002385) Erythrocyte distribution width [Ratio]
50
429
1.92
1.11
32.7
15.3
%
14.0
13.4
1.42
50
419
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
92
1.84
1.10
1.9
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
32
245
1.64
1.07
5.9
3.9
estimate
0.0
0.0
—
5
47
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
46
387
1.77
1.07
3.7
3.8
pmol/l
14.9
14.7
0.15
46
354
(3021589) Normoblasts [#/volume] in Blood
28
208
1.64
1.05
26.4
8.8
e9/l
0.0
0.0
0.00
22
167
(40760892) CBC W Ordered Manual Differential panel - Blood
18
119
1.73
1.03
7.8
5.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
46
389
1.74
1.03
3.7
3.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
17
111
1.74
1.02
4.0
4.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
19
129
1.69
0.99
3.8
2.6
mmol/l
7.4
8.1
0.26
19
114
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
6
27
2.35
0.96
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
57
1.90
0.90
3.7
8.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
6
31
2.03
0.87
2.5
2.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
31
246
1.53
0.83
9.4
5.3
estimate
0.0
0.0
—
5
48
(3029937) Albumin [Presence] in Urine by Test strip
20
144
1.58
0.82
4.3
3.9
estimate
0.0
0.0
—
5
47
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
24
0.00
0.81
0.0
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
18
127
1.59
0.80
3.4
3.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
23
2.27
0.78
2.2
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
9
55
1.74
0.78
1.7
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
5
24
2.18
0.76
2.0
11.9
%
82.2
93.0
—
5
24
(3020682) Albumin/Creatinine [Ratio] in Urine
16
111
1.60
0.76
4.3
3.7
mg/mmol
6.6
14.6
—
8
69
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
58
1.65
0.74
1.6
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
28
223
1.47
0.71
6.6
4.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
31
253
1.46
0.69
6.4
3.9
estimate
0.0
0.0
—
5
47
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
114
1.55
0.68
2.1
2.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
97
1.58
0.66
1.6
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
29
1.79
0.65
11.4
2.8
g/l
117.2
129.7
—
5
29
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
18
133
1.50
0.65
1.7
1.2
u/ml
0.3
0.7
—
5
31
(3009542) Hematocrit [Volume Fraction] of Blood
51
464
1.60
0.62
25.2
13.4
%
38.9
40.5
0.76
41
365
(21494755) Public health laboratory ask at order entry panel
8
54
1.55
0.60
1.5
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
37
1.69
0.57
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
19
149
1.40
0.50
6.4
3.1
—
—
—
0
0
(3013512) EKG study
16
124
1.39
0.44
5.1
3.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
16
124
1.39
0.44
1.8
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
24
200
1.33
0.43
6.3
3.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
125
1.38
0.42
1.8
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
33
1.56
0.42
4.2
4.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
34
1.51
0.41
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
42
1.47
0.37
1.7
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
16
128
1.34
0.37
2.1
1.7
mmol/l
1.7
1.3
0.72
16
115
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
103
1.33
0.31
2.0
2.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(4094501)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
10
0.00
0.21
0.0
2.0
—
4.1
—
0
10
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
10
0.00
0.21
0.0
2.0
—
106.3
—
0
10
(3008037) Lactate [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
2.1
—
1.5
—
0
12
(3038515) Glucose [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
2.1
—
7.6
—
0
12
(3003694) ABO and Rh group [Type] in Blood
18
160
1.18
0.16
1.7
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
163
1.15
0.12
2.2
2.0
—
—
—
0
0
(3000492) Spirometry study
5
45
1.12
0.10
2.0
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
6
57
1.06
0.09
2.5
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
10
107
0.92
0.02
1.3
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
17
177
0.95
0.01
3.1
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
33
325
1.03
0.00
4.5
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
19
186
1.03
0.00
2.3
2.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.4
—
832.3
—
0
7
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.1
—
593.4
—
0
7
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
62
0.96
0.00
2.3
2.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
2.5
—
0
9
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
27.3
—
0
5
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
7
73
0.95
0.00
6.6
2.9
ng/l
10.9
292.6
—
7
51
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
68
1.03
0.00
1.9
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
30.3
—
0
5
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
55
0.90
0.00
1.8
2.2
—
—
—
0
0
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
130.1
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint EHEC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have EHEC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: EHEC – Enterohaemorrhagic Escherichia coli infection
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data